Yuhan's Revanex expected to be in normal supply within this week
Published: 2008-02-22 06:57:00
Updated: 2008-02-22 06:57:00
Yuhan Corp. says it will address the acute shortage of Revanex (revaprazan) though its normal supply to wholesalers and pharmacies from February 20 at the latest. The company has attributed the shortage problem to ever-growing demand.
A novel proton pump inhibitor Revanex is now indicated for ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
